By Dr. Abhishek A. Mangaonkar Mayo Clinic The phase 2 FIGHT-203 trial (NCT#03011372) studied 28 patients with relapsed/refractory myeloid/lymphoid…
Dr. Luke Fletcher Willamette Valley Cancer Institute & Research Center Philadelphia positive acute lymphoblastic leukemia treatment has been driven…
Dr. Aditi Sharma of Barbara Ann Karmanos Cancer Institute & Dr. Abhishek Mangaonkar of Mayo Clinic In the phase…
By Luke Fletcher, MD Willamette Valley Cancer Institute & Research Center Imetelstat, a telomerase inhibitor, has shown interesting promise…
By Paolo Tarantino, MD Dana-Farber Cancer Institute/Harvard Medical School "Overall, a major shift in the way we treat breast…
Oncologists Interested in Improving Access to Cancer Care Encouraged to Apply Are you an oncologist who is passionate about educating…
ASH Review Portland, Highlights from SABCS, and Thoracic Oncology San Diego The Binaytara Foundation is facilitating three conferences with varying…
Meet Chris Nevala-Plagemann, MD, Katie Kerrigan, DO, and Theresa Werner, MD! In this week's faculty highlight, we present Drs. Chris…
Senior Fellows and Early Career Oncologists Interested in Cancer Health Disparities are Encouraged to Apply Interested in being mentored by…
Submit Your Research for Presentation at Our Cancer Disparities Summit The Binaytara Foundation invites you to submit your research for…